Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | GLA | P06280 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.67 |
| ▸ | CASP1 | P29466 | 1/20 | 0.67 |
| ▸ | CASP7 | P55210 | 1/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | NPC1 | O15118 | 5/20 | 0.58 |
| ▸ | RAB9A | P51151 | 5/20 | 0.58 |
| ▸ | TTR | P02766 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.53 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.52 |
| ▸ | TNKS | O95271 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31397562 | 1.00 | MAOA (0.67) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL30923496 | 0.90 | CYP11B1 (0.54) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL17752292 | 0.90 | CYP11B1 (0.54) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL30284875 | 0.89 | MAOA (0.67) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL2592127 | 0.89 | MAOA (0.67) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL29381559 | 0.88 | AHR (0.59) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL259160 | 0.88 | AHR (0.59) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL30593469 | 0.87 | PIM1 (0.51) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL47040 | 0.87 | PIM1 (0.51) | MAOAKDM4EALDH1A1GLACYP3A4 | |
| SCHEMBL28114240 | 0.86 | MAOA (0.58) | MAOAKDM4EALDH1A1GLACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112961157-A | Indolocarbazole-based organic luminescent material and preparation method and application thereof | 电子科技大学 | 2021-06-15 | — | — | CN | claimed |
| CN-105884830-A | Bipolar OLED (organic light-emitting diode) phosphorescence main body material and luminescent device containing material | 中节能万润股份有限公司 | 2016-08-24 | — | — | CN | claimed |
| EP-4692093-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | Solus Advanced Materials Co., Ltd. (KR) | 2026-02-11 | — | — | EP | disclosed |
| CN-119552596-A | Packaging adhesive suitable for high-speed cigarette making machine equipment and preparation method thereof | 郑州神火胶剂有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119143755-A | Method for preparing racemate from enantiomers of non-nefarious ketone or intermediate | 奥锐特药业股份有限公司 | 2024-12-17 | — | — | CN | disclosed |
| WO-2024205127-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 솔루스첨단소재 주식회사 | 2024-10-03 | — | — | WO | disclosed |
| CN-118255752-A | Organic light-emitting compound with sandwich-like structure and organic electronic device | 华南理工大学 | 2024-06-28 | — | — | CN | disclosed |
| CN-114249713-B | Organic compound containing xanthone or thioxanthone structure and application thereof | 江苏三月科技股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| US-11873294-B2 | Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices | JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) | 2024-01-16 | — | — | US | disclosed |
| US-11873294-B2 | Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices | JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) | 2024-01-16 | — | — | US | disclosed |
| US-11825741-B2 | Organic compound, organic light emitting diode and organic light emitting device including the organic compound | LG DISPLAY CO., LTD. (KR) | 2023-11-21 | — | — | US | disclosed |
| WO-2007030089-A1 | TRICYCLIC DELTA- OPIOID MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-03-15 | — | — | WO | disclosed |
| WO-2006069275-A1 | TRICYCLIC DELTA-OPIOID MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006069277-A1 | TRICYCLIC δ-OPIOID MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-06-29 | — | — | WO | disclosed |
| US-20060135524-A1 | Tricyclic delta-opioid modulators | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-06-22 | — | — | US | disclosed |
| US-20060135522-A1 | Tricyclic delta-opioid modulators | CARSON JOHN R | 2006-06-22 | — | — | US | disclosed |
| EP-1644373-A1 | TRICYCLIC DELTA OPIOID MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-04-12 | — | — | EP | disclosed |
| US-20060030585-A1 | Tricyclic delta-opioid modulators | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-02-09 | — | — | US | disclosed |
| WO-2005003131-A1 | TRICYCLIC DELTA OPIOID MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-01-13 | — | — | WO | disclosed |
| US-20050009860-A1 | Tricyclic delta-opioid modulators | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135524-A1 | Tricyclic delta-opioid modulators | OPRD1, OPRK1, OPRL1 | MAOA 948/4885KDM4E 2174/4885ALDH1A1 1302/4885 |
| US-11825741-B2 | Organic compound, organic light emitting diode and organic light emitting device including the organic compound | OCIAD2, OCIAD1, EML4 | MAOA 334/4885KDM4E 2583/4885ALDH1A1 1076/4885 |
| US-20050009860-A1 | Tricyclic delta-opioid modulators | OPRD1, OPRK1, OPRL1 | MAOA 948/4885KDM4E 2174/4885ALDH1A1 1302/4885 |
| US-20060030585-A1 | Tricyclic delta-opioid modulators | OPRD1, OPRK1, OPRL1 | MAOA 948/4885KDM4E 2174/4885ALDH1A1 1302/4885 |
| US-20060135522-A1 | Tricyclic delta-opioid modulators | OPRD1, OPRK1, OPRL1 | MAOA 948/4885KDM4E 2174/4885ALDH1A1 1302/4885 |
| US-11873294-B2 | Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices | NLRP1, OCIAD2, OCIAD1 | MAOA 189/4885KDM4E 2723/4885ALDH1A1 3143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.